Internal medicine, Relative risk, Risk factor, Body mass index and Epidemiology are his primary areas of study. His Internal medicine research incorporates elements of Endocrinology, Vitamin E and Population study. The Relative risk study combines topics in areas such as Diabetes mellitus, Type 2 diabetes, Cancer and Cohort study.
His study in Risk factor is interdisciplinary in nature, drawing from both Pediatrics, Depression and Low back pain. The various areas that Paul Knekt examines in his Body mass index study include Socioeconomic status, Obesity, Blood pressure and Medical record. His biological study spans a wide range of topics, including Health survey, Gerontology, Overweight, Public health and Physical therapy.
His main research concerns Internal medicine, Risk factor, Relative risk, Body mass index and Epidemiology. His research on Internal medicine often connects related areas such as Endocrinology. The study incorporates disciplines such as Physiology and Vitamin E in addition to Endocrinology.
In his study, Heart disease is inextricably linked to Population study, which falls within the broad field of Risk factor. His Relative risk research integrates issues from Surgery, Incidence, Diabetes mellitus, Type 2 diabetes and Cohort. His work carried out in the field of Body mass index brings together such families of science as Obesity and Gerontology.
His primary areas of investigation include Internal medicine, Clinical psychology, Mood, Psychodynamic psychotherapy and Anxiety disorder. His work on Cardiology expands to the thematically related Internal medicine. His Clinical psychology study combines topics in areas such as Pediatrics and Person-centered therapy.
Paul Knekt has included themes like Personality, Psychoanalysis and Beck Depression Inventory, Anxiety in his Mood study. His study looks at the relationship between Prospective cohort study and fields such as Cohort study, as well as how they intersect with chemical problems. His Hazard ratio research includes elements of Proportional hazards model, Confounding and Risk factor.
His primary areas of study are Internal medicine, Anxiety disorder, Mood, Psychodynamic psychotherapy and Clinical psychology. Many of his studies on Internal medicine apply to Diabetes mellitus as well. His Diabetes mellitus research includes themes of Relative risk and Surgery.
Paul Knekt interconnects Metabolic syndrome and Obesity in the investigation of issues within Relative risk. His Mood course of study focuses on Randomized controlled trial and Psychotherapist. His Risk factor research incorporates themes from Incidence, Population study, Vitamin D and neurology, Waist and Type 2 diabetes.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Flavonoid intake and risk of chronic diseases
Paul Knekt;Jorma Kumpulainen;Ritva Järvinen;Harri Rissanen.
The American Journal of Clinical Nutrition (2002)
Flavonoid intake and coronary mortality in Finland: a cohort study
Paul Knekt;Ritva Jarvinen;Antti Reunanen;Jouni Maatela.
BMJ (1996)
Genetic studies of body mass index yield new insights for obesity biology
Adam E. Locke;Bratati Kahali;Sonja I. Berndt;Anne E. Justice.
Faculty of Health; Institute of Health and Biomedical Innovation (2015)
Dietary Flavonoids and the Risk of Lung Cancer and Other Malignant Neoplasms
Paul Knekt;Ritva Järvinen;Ritva Seppänen;Markku Heliövaara.
American Journal of Epidemiology (1997)
Antioxidant Vitamin Intake and Coronary Mortality in a Longitudinal Population Study
P Knekt;A Reunanen;R Järvinen;R Seppänen.
American Journal of Epidemiology (1994)
Whole-grain and fiber intake and the incidence of type 2 diabetes
Jukka Montonen;Paul Knekt;Ritva Järvinen;Arpo Aromaa.
The American Journal of Clinical Nutrition (2003)
Prevalence, Determinants, and Consequences of Chronic Neck Pain in Finland
Matti Mäkela;Markku Heliövaara;Kai Sievers;Olli Impivaara.
American Journal of Epidemiology (1991)
Surgical or nonoperative treatment for lumbar spinal stenosis? A randomized controlled trial.
Antti Malmivaara;Pär Slätis;Markku Heliövaara;Päivi Sainio.
Spine (2007)
Determinants of weight gain and overweight in adult Finns.
A M Rissanen;M Heliövaara;P Knekt;A Reunanen.
European Journal of Clinical Nutrition (1991)
Schizophrenia, neuroleptic medication and mortality
Matti Joukamaa;Markku Heliövaara;Paul Knekt;Arpo Aromaa.
British Journal of Psychiatry (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
National Institutes of Health
Finnish Institute for Health and Welfare
Finnish Institute for Health and Welfare
Finnish Institute for Health and Welfare
Stanford University
Turku University Hospital
Finnish Institute for Health and Welfare
Icahn School of Medicine at Mount Sinai
Harvard Medical School
King's College London
The Open University
Microsoft (United States)
University of Oregon
University of California, Los Angeles
University of Pisa
University of Chicago
University of Washington
Chiba University
Lawrence Berkeley National Laboratory
University of Sheffield
Newcastle University
Meharry Medical College
University of Florida
York University
University of British Columbia
Johns Hopkins University